DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,164,520 | +12.2% | 2,042,283 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $26,876,101 | +30.1% | 2,080,193 | -1.2% | 0.00% | +50.0% |
| Q1 2023 | $20,653,091 | -4.9% | 2,105,310 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $21,713,239 | +47.3% | 2,040,718 | +44.5% | 0.00% | 0.0% |
| Q3 2022 | $14,743,000 | -21.1% | 1,412,061 | -4.9% | 0.00% | 0.0% |
| Q2 2022 | $18,690,000 | +36.5% | 1,484,463 | +17.5% | 0.00% | 0.0% |
| Q1 2022 | $13,696,000 | -31.8% | 1,263,385 | -11.4% | 0.00% | 0.0% |
| Q4 2021 | $20,070,000 | -44.2% | 1,426,519 | -23.9% | 0.00% | -60.0% |
| Q3 2021 | $35,991,000 | +104.2% | 1,873,546 | +4.7% | 0.01% | +150.0% |
| Q2 2021 | $17,629,000 | +176.6% | 1,789,695 | +176.1% | 0.00% | +100.0% |
| Q1 2021 | $6,373,000 | +216.3% | 648,233 | +43.1% | 0.00% | – |
| Q4 2020 | $2,015,000 | +12.8% | 452,929 | +9.5% | 0.00% | – |
| Q3 2020 | $1,787,000 | -64.5% | 413,805 | -27.1% | 0.00% | -100.0% |
| Q2 2020 | $5,034,000 | +265.8% | 567,684 | +45.7% | 0.00% | – |
| Q1 2020 | $1,376,000 | +12.3% | 389,723 | +82.0% | 0.00% | – |
| Q4 2019 | $1,225,000 | +275.8% | 214,106 | +135.0% | 0.00% | – |
| Q3 2019 | $326,000 | -82.8% | 91,127 | -80.8% | 0.00% | -100.0% |
| Q2 2019 | $1,890,000 | +117.2% | 473,794 | +298.0% | 0.00% | – |
| Q1 2019 | $870,000 | -81.8% | 119,034 | -77.2% | 0.00% | -100.0% |
| Q4 2018 | $4,771,000 | -25.3% | 521,312 | +1.2% | 0.00% | -50.0% |
| Q3 2018 | $6,388,000 | -24.7% | 515,105 | -7.4% | 0.00% | 0.0% |
| Q2 2018 | $8,483,000 | -6.4% | 556,227 | +21.8% | 0.00% | -33.3% |
| Q1 2018 | $9,062,000 | +14.1% | 456,529 | +7.5% | 0.00% | +50.0% |
| Q4 2017 | $7,944,000 | -37.1% | 424,773 | -27.7% | 0.00% | -50.0% |
| Q3 2017 | $12,625,000 | +634.4% | 587,244 | +229.7% | 0.00% | +300.0% |
| Q2 2017 | $1,719,000 | +24.9% | 178,123 | -23.1% | 0.00% | – |
| Q1 2017 | $1,376,000 | +11.0% | 231,716 | -26.2% | 0.00% | – |
| Q4 2016 | $1,240,000 | -80.4% | 313,952 | -48.1% | 0.00% | -100.0% |
| Q3 2016 | $6,340,000 | +49.8% | 604,358 | +108.2% | 0.00% | 0.0% |
| Q2 2016 | $4,233,000 | +74.8% | 290,285 | +130.6% | 0.00% | +100.0% |
| Q1 2016 | $2,422,000 | +35.4% | 125,904 | +69.9% | 0.00% | 0.0% |
| Q4 2015 | $1,789,000 | -44.0% | 74,089 | -43.1% | 0.00% | 0.0% |
| Q3 2015 | $3,194,000 | -26.0% | 130,168 | -29.4% | 0.00% | 0.0% |
| Q2 2015 | $4,316,000 | +31.3% | 184,247 | +25.7% | 0.00% | 0.0% |
| Q1 2015 | $3,288,000 | +22.6% | 146,600 | -7.8% | 0.00% | 0.0% |
| Q4 2014 | $2,682,000 | – | 159,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |